Back

Beyond conventional markers: Navigating the complex prognostic landscape of galectin-3 and Lp(a) in predicting MACE in post-PTCA procedure

29 August 2026 (15:15 - 15:45)
Organised by: Logo
Congress Presentation Part of: Valvular disease, coronary interventions, and imaging innovations Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Faqrizal Ria Qhabibi

National Cardiovascular Center Harapan Kita, Jakarta (Indonesia)

3 More presentations in this session

Presentation thumbnail
Long noncoding RNA H19 is elevated in aortic valve stenosis and governs angiogenic response and valvular endothelial cell phenotypes through endothelial to mesenchymal transition
Doctor M. Hosen (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Coronary porcine studies of mechanical, morphometric, and physiological performance based on OCT /angiography of CD31‑endothelial‑mimetic coating stent, drug-eluting stent and bare metal stent
Doctor C. Shih (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Pericardium tissue layer and calcification characteristics - polarization-sensitive optical coherence tomography as material analysis tool for aortic valve bioprosthesis fabrication
Doctor C. Dittfeld (Dresden, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular disease, coronary interventions, and imaging innovations

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography
3 September 2019
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
28 August 2020
thumbnail
Congress Presentation
Restenosis after drug-coated balloon therapy for in-stent restenosis: an overview of case findings
1 September 2025
thumbnail
Congress Presentation
Beyond NT-proBNP: novel biomarkers enhance short- and intermediate-term risk prediction in tricuspid valve interventions
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources